168
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The evolution of ACE inhibition – A turning point in cardiovascular medicine

, &
Pages 5-6 | Published online: 08 Jul 2009

References

  • Aurell M. The renin–angiotensin system: The centenary jubilee. Blood Press 1998; 7: 71–75
  • Hedner T., Hansson L., Himmelmann A. The renin–angiotensin system – A century of progress. Blood Press 1998; 7: 68–70
  • Borghi C., Bacchelli S., Degli Esposti D., Ambrosioni E. A review of the angiotensin‐converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases. Expert Opin Pharmacother 2004; 5: 1965–1977
  • Cooper M. E. The role of the renin–angiotensin‐aldosterone system in diabetes and its vascular complications. Am J Hypertens 2004; 17: 16S–20S
  • McMurray J. J. Angiotensin inhibition in heart failure. J Renin Angiotensin Aldosterone Syst 2004; 5(Suppl 1)S17–22
  • Parati G., Omboni S., Malacco E., on behalf of the Study Group. Antihypertensive efficacy of zofenopril and hydrochlorothiazide combination on ambulatory blood pressure. Blood Press 2006; 15(Suppl 1)7–17
  • Zanchetti A., Parati G., Malacco E. Zofenopril plus Hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. Drugs 2006; 66: 1107–1115
  • Narkiewicz K. Comparison of home and office blood pressure in hypertensive patients treated with zofenopril or losartan. Blood Press 2007; 16(Suppl)7–12
  • Mallion J. ‐. M. An evaluation of the initial and long‐term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension. Blood Press 2007; 16(Suppl)13–18
  • Farsang C. Blood pressure control and response rates with zofenopril compared with amlodipine in hypertensive patients. Blood Press 2007; 16(Suppl)19–24
  • Nilsson P. Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension. Blood Press 2007; 16(Suppl)25–30
  • Ambrosioni E., Borghi C., Magnani B., for the Survival of Myocardial Infarction Long‐Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin‐converting–enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. New Engl J Med 1995; 332: 80–85
  • Borghi C., Ambrosioni E., Magnani B. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long‐term Evaluation. Am J Cardiol 1996; 78: 317–322
  • Borghi C., Bacchelli S., Esposti D. D., Bignamini A., Magnani B., Ambrosioni E. Effects of the administration of an angiotensin‐converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long‐term Evaluation. Am J Hypertens 1999; 12: 665–672
  • Borghi C., Ambrosioni E., Survival of Myocardial Infarction Long‐term Evaluation‐2 Working Party. Double‐blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long‐term Evaluation‐2 (SMILE‐2) study. Am Heart J 2003; 45: 80–87

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.